Showing results (351-360 of 379) with videos related to
Sort By:
Pageof 38
The Lancet. Global Health|January 31, 2025
Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative designRadhika Gharpure, Annette K Regan, Francisco Nogareda, et al.Emerging Infectious Diseases|January 28, 2015
Melioidosis diagnostic workshop, 2013Alex R Hoffmaster, David AuCoin, Prasith Baccam, et al.MMWR. Morbidity and Mortality Weekly Report|September 25, 2025
Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025Savanah Russ, Francisco Nogareda, Annette K Regan, et al.Nature Communications|May 12, 2021
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patientsThi H O Nguyen, Marios Koutsakos, Carolien E van de Sandt, et al.Annals of the American Thoracic Society|April 9, 2020
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C Angus, Scott Berry, Roger J Lewis, et al.Nature Communications|November 24, 2025
High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signaturesAira F Cabug, Jeremy Chase Crawford, Hayley A McQuilten, et al.Nature Immunology|February 20, 2019
Human CD8+ T cell cross-reactivity across influenza A, B and C virusesMarios Koutsakos, Patricia T Illing, Thi H O Nguyen, et al.Ebiomedicine|December 6, 2021
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Thomas S Fulford, Huy Van, Nicholas A Gherardin, et al.Nature Communications|May 19, 2021
CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorphLuca Hensen, Patricia T Illing, E Bridie Clemens, et al.Immunity|May 5, 2021
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuityThi H O Nguyen, Louise C Rowntree, Jan Petersen, et al.Pageof 38